gram-negative

(redirected from Gram negative)
Also found in: Dictionary, Thesaurus, Medical.
Related to Gram negative: Gram positive

gram-negative

[′gram¦neg·əd·iv]

(microbiology)

Of bacteria, decolorizing and staining with the counterstain when treated with Gram's stain.

References in periodicals archive ?

Isolates Gram staining Cell Colony morphology diameter (d) mm SE 1 Red, Gram negative Rods 17.

Characterization of potential phosphate solubilizing bacteria from the local paddy fields in Perlis

Tachypleus lysate test for endotoxin in patients with gram negative bacterial infections.

Concordance of Endotoxemia With Gram-Negative Bacteremia

Novel antibiotics targeting Gram negative infections

Research and Markets: Cubist's CXA-201 - A Novel Antibiotic for Gram-negative Infections

The research will focus on such Gram negative pathogens as Pseudomonas, Klebsiella and Acinetobacter, which are increasingly resistant to all known classes of antibiotics.

GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program

With Spectral's new test, information on the absence of gram negative infection can be available within one hour.

Spectral Diagnostics Inc. Announces FDA Submission of its Test for "Ruling Out" Gram Negative Infection

PZ-601 is a new carbapenem antibiotic with an extended spectrum of activity against multidrug-resistant Gram positive and Gram negative pathogens.

Protez Initiates Phase II Study for Its Lead Product PZ-601 in Infectious Diseases

s gram negative test, the first in a family of diagnostic tests, is intended to provide additional diagnostic information to physicians in one hour.

Spectral Diagnostics Inc. announces acquisition of additional interest in Sepsis Inc

The gram negative diagnostic test, the first product in a series under development at Sepsis Inc.

Spectral Diagnostics Inc. announces progress of the gram negative diagnostic test clinical trial

Quorex has applied its proprietary technologies, including target molecular structures, computational chemistry, high-throughput screening assays and a powerful bioinformatics platform to effectively design, synthesize and identify compounds that dramatically inhibit the quorum sensing pathway in both Gram negative and Gram positive pathogens.

Quorex Pharmaceuticals Names Dr. Krzysztof Appelt Senior Vice President, Drug Development

will enable physicians to rule-out gram negative infection in less than 60 minutes compared to traditional methods that require hours or days to culture infectious organisms.

Spectral Diagnostics Inc. Announces US$1.0 Million Funding Milestone From Elan For Clinical Trials

Extension of the SBIR phase I research includes analyses of other pathogens, both gram positive and gram negative, and focuses on targets found in a broad spectrum of microbes.

Protein Pathways Receives $100,000 SBIR Phase I Grant

Drugs which interfere with the assembly of pili should effectively disable pathogens responsible for a broad variety of gram negative infections, such as those resulting in bladder, kidney and middle ear infections.